GlassScriptPhysician profile
Julia Shuleshko
NPI 1588602858
$6,657.44
in general payments reported to CMS, 2019-2025
11 companies · $428 in 2025
The $428 reported for 2025 was more than what 92% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $52.44 · 2021: $37.55 · 2022: $1,755 · 2023: $1,901 · 2024: $1,466 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,405 · Travel and Lodging: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,404.69 |
| Travel and Lodging | $389.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $5,219.29 | 2022-2025 | |
| Musculoskeletal Transplant Foundation INC. | $457.05 | 2019-2023 | |
| Teva Pharmaceuticals USA, INC. | $249.60 | 2019 | |
| Smith+Nephew, INC. | $163.70 | 2019-2023 | Collagenase Santyl |
| Osiris Therapeutics INC. | $141.20 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2019 | |
| Boston Scientific Corporation | $110.03 | 2019 | |
| Medtronic, INC. | $91.32 | 2023 | Percept PC Brainsense |
| Mimedx Group, INC. | $71.42 | 2025 | |
| Convatec INC. | $14.53 | 2022 | |
| Kci USA, INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Shuleshko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.